Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Prospective, Single-blind, Randomized, Placebo-controlled, Clinical Trial Evaluating Reduction in Severity and Duration of Symptoms After Laser Therapy With Acorn aHFS

Authors not listed

Acorn Biolabs Inc. · 2024

Dysbiosis Human Randomized controlled trial

Abstract

This study evaluates the severity and duration of symptoms experienced after laser therapy comparing four post-procedure topical products. Each product is applied to an individual region of interest (5 cm diameter) on the back or décolleté according to randomization code after laser therapy. The subject, blind to the product applied to each of 4 regions of interest, assesses eight symptoms daily for 14 days. Photography is performed daily.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-17 MST

Cite this

APA

Anonymous. (2024). A Prospective, Single-blind, Randomized, Placebo-controlled, Clinical Trial Evaluating Reduction in Severity and Duration of Symptoms After Laser Therapy With Acorn aHFS. <em>Acorn Biolabs Inc.</em>. https://clinicaltrials.gov/study/NCT06336135

Vancouver

Anonymous. A Prospective, Single-blind, Randomized, Placebo-controlled, Clinical Trial Evaluating Reduction in Severity and Duration of Symptoms After Laser Therapy With Acorn aHFS. Acorn Biolabs Inc.. 2024.

BibTeX

@misc{anon2024AProsp, title = {A Prospective, Single-blind, Randomized, Placebo-controlled, Clinical Trial Evaluating Reduction in Severity and Duration of Symptoms After Laser Therapy With Acorn aHFS}, author = {Anonymous}, journal = {Acorn Biolabs Inc.}, year = {2024}, }